Allogeneic platelet lysate activates the SIRT1-PINK1/Parkin pathway: A promising approach for improving mitochondrial function in an in vitro model of intervertebral disc degeneration DOI Creative Commons
Zhili Ding, Wei Du, Jie Huang

et al.

International Immunopharmacology, Journal Year: 2024, Volume and Issue: 144, P. 113700 - 113700

Published: Dec. 3, 2024

Language: Английский

Chondrocyte-targeted exosome-mediated delivery of Nrf2 alleviates cartilaginous endplate degeneration by modulating mitochondrial fission DOI Creative Commons
Zhidi Lin, Guangyu Xu, Xiao Lu

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: May 24, 2024

Abstract Background Cartilaginous endplate (CEP) degeneration, which is an important contributor to intervertebral disc degeneration (IVDD), characterized by chondrocyte death. Accumulating evidence has revealed that dynamin-related protein 1 (Drp1)-mediated mitochondrial fission and dysfunction lead apoptosis during CEP IVDD. Exosomes are promising agents for the treatment of many diseases, including osteoporosis, osteosarcoma, osteoarthritis Despite their major success in drug delivery, full potential exosomes remains untapped. Materials methods In vitro vivo models were established using lipopolysaccharide (LPS). We designed genetically engineered (CAP-Nrf2-Exos) expressing chondrocyte-affinity peptide (CAP) on surface carrying antioxidant transcription factor nuclear E2-related 2 (Nrf2). The affinity between CAP-Nrf2-Exos was evaluated internalization assays imaging assays. qRT‒PCR, Western blotting immunofluorescence performed examine expression level Nrf2 subcellular localization Drp1. Mitochondrial function measured JC-1 probe MitoSOX Red. morphology visualized MitoTracker staining transmission electron microscopy (TEM). After subendplate injection exosomes, degree IVDD validated radiologically histologically. Results found cargo delivery efficiency after packaging increased modification. facilitated chondrocyte-targeted activated endogenous defence system cells. inhibited Drp1 S616 phosphorylation translocation, thereby preventing fragmentation dysfunction. LPS-induced cell alleviated CAP-Nrf2-Exo treatment. a rat model successfully attenuated exhibited better repair capacity than natural exosomes. Conclusion Collectively, our findings showed exosome-mediated effective strategy treating degeneration. Graphic abstract delivered into cells inhibiting Drp1-mediated

Language: Английский

Citations

9

Discogenic Low Back Pain: Anatomic and Pathophysiologic Characterization, Clinical Evaluation, Biomarkers, AI, and Treatment Options DOI Open Access
Matteo De Simone, Anis Choucha, Elena Ciaglia

et al.

Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(19), P. 5915 - 5915

Published: Oct. 3, 2024

Discogenic low back pain (LBP) is a significant clinical condition arising from degeneration of the intervertebral disc, common yet complex cause chronic pain, defined by fissuring in annulus fibrosus resulting vascularization growing granulation tissue and growth nociceptive nerve fibers along laceration area. This paper delves into anatomical pathophysiological underpinnings discogenic LBP, emphasizing role disc onset pain. The pathogenesis multifactorial, involving processes like mitochondrial dysfunction, accumulation advanced glycation end products, pyroptosis, all contributing to subsequent Despite its prevalence, diagnosing LBP challenging due overlapping symptoms with other forms absence definitive diagnostic criteria. Current approaches include evaluations, imaging techniques, exploration potential biomarkers. Treatment strategies range conservative management, such as physical therapy pharmacological interventions, more invasive procedures spinal injections surgery. Emerging therapies targeting molecular pathways involved are under investigation hold for future application. highlights necessity multidisciplinary approach combining clinical, imaging, data enhance accuracy diagnosis effectiveness treatment ultimately aiming improve patient outcomes.

Language: Английский

Citations

8

Mesenchymal stem cells-derived exosomes attenuate mouse non-heart-beating liver transplantation through Mir-17-5p-regulated Kupffer cell pyroptosis DOI Creative Commons
Yang Tian, Ming Jin,

Nanwei Ye

et al.

Stem Cell Research & Therapy, Journal Year: 2025, Volume and Issue: 16(1)

Published: Feb. 7, 2025

Liver transplantation is the most effective treatment for end-stage liver disease. However, shortage of donor livers has become a significant obstacle to advancement transplantation. Mesenchymal stem cells-derived exosomes (MSCs-Exo) have been extensively investigated in diseases. underlying mechanisms how they can protect organ donation after cardiac death (DCD) remain unclear. In this study, an arterialized mouse non-heart-beating (NHB) model was used investigate effect MSCs-Exo on NHB The survival rates, histology, pro-inflammatory cytokine and chemokine expression, were investigated. infusion reduced injury DCD graft tissue. vitro vivo experiments demonstrated that could inhibit hydrogen peroxide-induced pyroptosis Kupffer cells. We found miR-17-5p significantly abundant MSCs-Exo, targeting regulating TXNIP expression. This action inhibited NLRP3-mediated cells through classical Caspase1-dependent pathway, alleviating injury. Our study elucidated protective role model. mechanism provides theoretical basis new strategies clinical application improve quality alleviate

Language: Английский

Citations

1

Pyroptosis: candidate key targets for mesenchymal stem cell-derived exosomes for the treatment of bone-related diseases DOI Creative Commons
Hong Li, Peng Zhang, Minghui Lin

et al.

Stem Cell Research & Therapy, Journal Year: 2025, Volume and Issue: 16(1)

Published: Feb. 12, 2025

Bone-related diseases impact a large portion of the global population and, due to their high disability rates and limited treatment options, pose significant medical economic challenges. Mesenchymal stem cells (MSCs) can differentiate into multiple cell types offer strong regenerative potential, making them promising for treating various diseases. However, issues with immune response survival limit effectiveness transplantation. This has led increased interest in cell-free therapy, particularly use exosomes, which is most studied form this approach. Exosomes are extracellular vesicles that contain proteins, lipids, nucleic acids play key role communication material exchange. Pyroptosis, death involved innate immunity, also associated many Studies have shown MSC-derived exosomes therapeutic potential range conditions by regulating inflammation pyroptosis. study explored modulating pyroptosis improve bone-related

Language: Английский

Citations

1

From drugs to biomaterials: a review of emerging therapeutic strategies for intervertebral disc inflammation DOI Creative Commons

Shuhan Yang,

Shaoze Jing,

Shanxi Wang

et al.

Frontiers in Cellular and Infection Microbiology, Journal Year: 2024, Volume and Issue: 14

Published: Jan. 30, 2024

Chronic low back pain (LBP) is an increasingly prevalent issue, especially among aging populations. A major underlying cause of LBP intervertebral disc degeneration (IDD), often triggered by (IVD) inflammation. Inflammation the IVD divided into Septic and Aseptic Conservative therapy surgical treatment fail to address root IDD. Recent advances in infection inflammation range from antibiotics small-molecule drugs cellular therapies, biological agents, innovative biomaterials. This review sheds light on complex mechanisms physiological biochemical processes Furthermore, it provides overview recent research developments this area, intending identify novel therapeutic targets guide future clinical strategies for effectively treating IVD-related conditions.

Language: Английский

Citations

4

Exosomes derived from HMVEC with inflammation induce chondrocyte pyroptosis and promote intervertebral disc degeneration DOI
Fan Zhang,

Ding Heng,

Le Hu

et al.

Journal of Orthopaedics, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Language: Английский

Citations

0

Navigating the tumor microenvironment: mesenchymal stem cell-mediated delivery of anticancer agents DOI
Muhammad Ahsan Waqar, Muhammad Zaman,

Rabeel Khan

et al.

Journal of drug targeting, Journal Year: 2024, Volume and Issue: 32(6), P. 624 - 634

Published: April 23, 2024

Scientific knowledge of cancer has advanced greatly throughout the years, with most recent studies findings includes many hallmarks that capture disease's multifaceted character. One novel approach utilized for delivery anti-cancer agents mesenchymal stem cell mediated drug delivery. Mesenchymal cells (MSCs) are non-hematopoietic progenitor may be extracted from bone marrow, tooth pulp, adipose tissue and placenta/umbilical cord blood dealing adult cells. MSCs mostly involved in regeneration tissue, they have also been shown to preferentially migrate location several types tumor in-vivo. Usage ought improve both effectiveness safety drugs by enhancing efficiency therapies site. Numerous researches demonstrated various drugs, when delivered via can elicit anti-tumor effect cancers breast thyroid minimal immunogenicity because lack co-stimulatory molecule expression, which means there is no requirement immunosuppression after allogenic transplantation. This current review elaborates advancements mesenchyma along its mechanism previously reported manufactured this system.

Language: Английский

Citations

3

Exploration and breakthrough in the mode of intervertebral disc cell death may lead to significant advances in treatments for intervertebral disc degeneration DOI Creative Commons
Chen Heng, Tian Tang, Congyang Xue

et al.

Journal of Orthopaedic Surgery and Research, Journal Year: 2024, Volume and Issue: 19(1)

Published: Dec. 5, 2024

Low back pain caused by intervertebral disc degeneration (IDD) has emerged as a significant global public health concern, with far-reaching consequences for patients' quality of life and healthcare systems. Although previous research have revealed that the mechanisms cell apoptosis, pyroptosis necroptosis can aggravate IDD damage mediating inflammation promoting extracellular matrix degradation, but they cannot explain connection between different death ion metabolism disorders. The latest study shows such cellular senescence, ferroptosis, cuproptosis, PANopotosis similar roles in progression degeneration, not exactly same mechanism. This paper summarizes effects various patterns on disease IDD, related molecular signaling pathways, providing new perspectives potential clinical intervention strategies prevention treatment IDD.

Language: Английский

Citations

3

Protective Effect of Mesenchymal Stem Cell Active Factor Combined with Alhagi maurorum Extract on Ulcerative Colitis and the Underlying Mechanism DOI Open Access

Xuanhong Cao,

Aili Aierken, Jie Wang

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(7), P. 3653 - 3653

Published: March 25, 2024

Ulcerative colitis (UC) is a relapsing and reoccurring inflammatory bowel disease. The treatment effect of Alhagi maurorum stem cell extracts on UC remains unclear. aim the present study was to investigate protective role combined with extract intestinal mucosal barrier in an inflammation mouse model. Sixty mice were randomly divided into control group, model MSC MSC/Alhagi group. found reduce disease activity index (DAI) scores colitis, alleviate weight loss, improve (p < 0.05), preserve integrity ileal wall increase number goblet cells mucin colon tissues. Little infiltration observed Alhagi, MSC, or groups, degree significantly alleviated compared that distribution PCNA TNF-alpha colonic tissues group more disperse than normal fluorescence intensity lower. After intervention, distributed along cellular membrane 0.05). Compared slightly reduced, but it still stronger In conclusion, can reactions tissue, possibly by strengthening barrier.

Language: Английский

Citations

2

An Update on Emerging Regenerative Medicine Applications: The Use of Extracellular Vesicles and Exosomes for the Management of Chronic Pain DOI
William Shipman, Raquel Fonseca, Moises Dominguez

et al.

Current Pain and Headache Reports, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 4, 2024

Language: Английский

Citations

2